C. Mauri

发表

Importance of cyclophosphamide-induced bystander effect on T cells for a successful tumor eradication in response to adoptive immunotherapy in mice.

E. Proietti, F. Belardelli, G. Greco, 1998, The Journal of clinical investigation.

Monocyte NOTCH 2 expression predicts IFN-b immunogenicity in multiple sclerosis patients

P. Dönnes, B. Hemmer, E. Havrdová, 2018 .

Canonical pathway of nuclear factor kappa B activation selectively regulates proinflammatory and prothrombotic responses in human atherosclerosis.

N. Cheshire, M. Feldmann, C. Monaco, 2004, Proceedings of the National Academy of Sciences of the United States of America.

Interleukin-10 produced by B cells is crucial for the suppression of Th17/Th1 responses, induction of T regulatory type 1 cells and reduction of collagen-induced arthritis

E. Rosser, C. Mauri, N. Carter, 2012, Arthritis Research & Therapy.

Is there a feudal hierarchy amongst regulatory immune cells? More than just Tregs

C. Mauri, N. Carter, 2009, Arthritis research & therapy.

CD1d-dependent immune suppression mediated by regulatory B cells through modulations of iNKT cells

I. Drozdov, E. Rosser, C. Mauri, 2018, Nature Communications.

Compromised function of regulatory T cells in rheumatoid arthritis: Reversal by anti-TNF alpha therapy

Ehrenstein, C. Mauri, 2004 .

Prevention of Arthritis by Interleukin 10–producing B Cells

D. Gray, N. Mushtaq, M. Londei, 2003, The Journal of experimental medicine.

The emerging field of regulatory B cell immunometabolism.

E. Rosser, C. Mauri, 2021, Cell metabolism.

Aryl Hydrocarbon Receptor Contributes to the Transcriptional Program of IL-10-Producing Regulatory B Cells

André F. Rendeiro, I. Drozdov, B. Stockinger, 2019, Cell reports.

Effector and regulatory B cells in immune-mediated kidney disease

A. Salama, C. Mauri, K. Oleinika, 2018, Nature Reviews Nephrology.

TIM-1 defines a human regulatory B cell population that is altered in frequency and function in systemic sclerosis patients

M. Menon, J. Aguillón, C. Mauri, 2017, Arthritis Research & Therapy.

Cytokine-Producing Effector B Cells

E. Rosser, C. Mauri, 2016 .

The expanding family of regulatory B cells

M. Menon, C. Mauri, 2015, International immunology.

Regulatory B cells: origin, phenotype, and function.

E. Rosser, C. Mauri, 2015, Immunity.

Interleukin-35 takes the 'B' line

C. Mauri, K. Nistala, 2014, Nature Medicine.

The incognito journey of a regulatory B cell.

C. Mauri, P. Blair, 2014, Immunity.

The 'short' history of regulatory B cells.

M. Ehrenstein, C. Mauri, 2008, Trends in immunology.

Capacity in Healthy Individuals but Are Functionally Impaired in Systemic Lupus Erythematosus Patients

D. Isenberg, D. Rawlings, M. Ehrenstein, 2010 .

Erythematosus from Patients with Systemic Lupus Lipid Raft-Associated Signaling in T Cells Atorvastatin Restores Lck Expression and

D. Isenberg, M. Ehrenstein, C. Mauri, 2006 .

Differential levels of IFNα subtypes in autoimmunity and viral infection

I. Bruce, B. Schwikowski, D. Isenberg, 2021, bioRxiv.

Dynamics of proinflammatory cytokine expression in the joints of mice with collagen‐induced arthritis (CIA)

M. Feldmann, Richard O. Williams, R. Maini, 1997, Clinical and experimental immunology.

Circulating and intrahepatic antiviral B cells are defective in hepatitis B

Leo Swadling, N. Pelletier, B. Davidson, 2018, The Journal of clinical investigation.

Inactive disease in lupus patients is linked to autoantibodies to type-I interferons that normalize blood IFNÎ± and B cell subsets

D. Isenberg, P. Peterson, M. Menon, 2021, medRxiv.

Regulatory B cells are numerically but not functionally deficient in anti-neutrophil cytoplasm antibody-associated vasculitis.

A. Salama, C. Pusey, R. Pepper, 2014, Rheumatology.

Defects in CTLA-4 are associated with abnormal regulatory T cell function in rheumatoid arthritis

M. Ehrenstein, C. Mauri, E. Jury, 2008, Proceedings of the National Academy of Sciences.

Down-regulation of Th1-mediated pathology in experimental arthritis by stimulation of the Th2 arm of the immune response.

M. Feldmann, Richard O. Williams, C. Mauri, 2003, Arthritis and rheumatism.

Intestinal barrier dysfunction plays an integral role in arthritis pathology and can be targeted to ameliorate disease

M. Menon, E. Rosser, N. Klein, 2021, Med.

Cells of the synovium in rheumatoid arthritis. B cells

M. Ehrenstein, C. Mauri, 2007, Arthritis research & therapy.

Novel Frontiers in Regulatory B cells

C. Mauri, 2021, Immunological reviews.

CD19+CD24hiCD38hi B Cells Are Expanded in Juvenile Dermatomyositis and Exhibit a Pro-Inflammatory Phenotype After Activation Through Toll-Like Receptor 7 and Interferon-α

D. Isenberg, P. Beales, A. Radziszewska, 2018, Front. Immunol..

Regulation of immunity and autoimmunity by B cells.

C. Mauri, 2010, Current opinion in immunology.

Novel Suppressive Function of Transitional 2 B Cells in Experimental Arthritis1

D. Rawlings, M. Ehrenstein, C. Mauri, 2007, The Journal of Immunology.

Selective Targeting of B Cells with Agonistic Anti-CD40 Is an Efficacious Strategy for the Generation of Induced Regulatory T2-Like B Cells and for the Suppression of Lupus in MRL/lpr Mice1

D. Isenberg, M. Shlomchik, M. Ehrenstein, 2009, The Journal of Immunology.

IL-10–Producing Regulatory B Cells in the Pathogenesis of Chronic Hepatitis B Virus Infection

P. Lampertico, M. Brunetto, M. Maini, 2012, The Journal of Immunology.

Mice Lacking Endogenous IL-10–Producing Regulatory B Cells Develop Exacerbated Disease and Present with an Increased Frequency of Th1/Th17 but a Decrease in Regulatory T Cells

R. Flavell, E. Rosser, M. Ehrenstein, 2011, The Journal of Immunology.

Regulatory B cells in autoimmunity: developments and controversies

C. Mauri, P. Blair, 2010, Nature Reviews Rheumatology.

Natural serum IgM maintains immunological homeostasis and prevents autoimmunity

J. Manson, M. Ehrenstein, C. Mauri, 2005, Springer Seminars in Immunopathology.

Abnormal CTLA‐4 function in T cells from patients with systemic lupus erythematosus

D. Isenberg, H. Kalsi, M. Ehrenstein, 2010, European journal of immunology.

Anti–TNF-α therapy induces a distinct regulatory T cell population in patients with rheumatoid arthritis via TGF-β

M. Ehrenstein, C. Mauri, S. Nadkarni, 2007, The Journal of experimental medicine.

If the treatment works, do we need to know why?: the promise of immunotherapy for experimental medicine

M. Ehrenstein, C. Mauri, 2007, The Journal of experimental medicine.

This information is current as Regulatory T Cells Frequency of Th 1 / Th 17 but a Decrease in Disease and Present with an Increased Regulatory B Cells Develop Exacerbated Producing − Mice Lacking Endogenous IL-10

R. Flavell, E. Rosser, M. Ehrenstein, 2011 .

Definitive childlessness in women with multiple sclerosis: a multicenter study

L. Caniatti, M. Tola, P. Sola, 2017, Neurological Sciences.

Lipid-Antigen Presentation by CD1d+ B Cells Is Essential for the Maintenance of Invariant Natural Killer T Cells

D. Isenberg, C. Mauri, E. Jury, 2012, Immunity.

Presence of anti-rituximab antibodies predicts infusion-related reactions in patients with systemic lupus erythematosus

D. Isenberg, M. Menon, C. Mauri, 2018, Annals of the rheumatic diseases.

B regulatory cells are increased in hypercholesterolaemic mice and protect from lesion development via IL-10

M. Goddard, E. Rosser, C. Monaco, 2015, Thrombosis and Haemostasis.

Therapeutic activity of agonistic anti-CD40 mAb in a chronic autoimmune inflammatory process

M. Londei, C. Mauri, L. Mars, 2000 .

Immunoregulatory potential of T2-MZP B cells

M. Ehrenstein, C. Mauri, P. Blair, 2008 .

Immunotherapeutic maintenance treatment with toll-like receptor 9 agonist lefitolimod in patients with extensive-stage small-cell lung cancer: results from the exploratory, controlled, randomized, international phase II IMPULSE study

A. Navarro, R. Huber, M. Thomas, 2018, Annals of oncology : official journal of the European Society for Medical Oncology.

The many faces of type I interferon in systemic lupus erythematosus.

M. Menon, C. Mauri, 2015, The Journal of clinical investigation.

Biosprayed spleen cells integrate and function in mouse models.

S. Jayasinghe, C. Mauri, N. Carter, 2011, The Analyst.

IL-12p35 Subunit Contributes to Autoimmunity by Limiting IL-27–Driven Regulatory Responses

E. Rosser, C. Mauri, N. Carter, 2011, The Journal of Immunology.

Autoimmunity by Limiting IL-27 IL-12 p 35 Subunit Contributes to and

E. Rosser, C. Mauri, N. Carter, 2011 .

The quest for personalized B-cell depletion therapy in rheumatic disease

C. Mauri, K. Nistala, 2014, Arthritis Research & Therapy.

Low Percentage of Signal Regulatory Protein α/β+ Memory B Cells in Blood Predicts Development of Anti-drug Antibodies (ADA) in Adalimumab-Treated Rheumatoid Arthritis Patients

D. Isenberg, X. Mariette, M. Pallardy, 2018, Front. Immunol..

Regulatory B Cells in Experimental Mouse Models of Arthritis.

E. Rosser, C. Mauri, D. E. Matei, 2021, Methods in molecular biology.

Regulatory B cells in CVID patients fail to suppress multifunctional IFN-γ+ TNF-α+ CD4+ T cells differentiation.

T. Kalina, M. Vlková, J. Litzman, 2015, Clinical immunology.

Regulatory B cells are enriched within the IgM memory and transitional subsets in healthy donors but are deficient in chronic GVHD.

K. Rezvani, S. Parmar, E. Shpall, 2014, Blood.

Regulatory B cells in experimental mouse models of arthritis.

E. Rosser, C. Mauri, 2014, Methods in molecular biology.

Treatment of a newly established transgenic model of chronic arthritis with nondepleting anti-CD4 monoclonal antibody.

D. Woodrow, L. Mori, M. Londei, 1997, Journal of immunology.

Invariant natural killer T cells are enriched at the site of cutaneous inflammation in lupus erythematosus.

D. Isenberg, L. Bruckner-Tuderman, C. Mauri, 2013, Journal of dermatological science.

A comparative study into the mechanisms of action of anti-tumor necrosis factor alpha, anti-CD4, and combined anti-tumor necrosis factor alpha/anti-CD4 treatment in early collagen-induced arthritis.

M. Feldmann, P. Taylor, R. N. Maini, 2000, Arthritis and rheumatism.

Identification and Isolation of Regulatory B Cells in Mouse and Human.

M. Menon, E. Rosser, C. Mauri, 2019, Methods in molecular biology.

IL-10 secreting regulatory B cells are potent arbiters of autoimmunity in both mouse and man

C. Mauri, F. Flores-Borja, N. Carter, 2011, Journal of Translational Medicine.

Therapeutic actions of cyclosporine and anti-tumor necrosis factor alpha in collagen-induced arthritis and the effect of combination therapy.

M. Feldmann, R. Maini, L. Marinova-Mutafchieva, 1998, Arthritis and rheumatism.

Type I IFN Protects Permissive Macrophages from Legionella pneumophila Infection through an IFN-γ-Independent Pathway1

E. Proietti, F. Belardelli, G. Schiavoni, 2004, The Journal of Immunology.

Suppression of TNF-alpha expression, inhibition of Th1 activity, and amelioration of collagen-induced arthritis by rolipram.

M. Feldmann, Richard O. Williams, R. Maini, 1997, Journal of immunology.

25-hydroxycholesterol: Gatekeeper of intestinal IgA.

C. Mauri, C. Piper, 2021, Immunity.

Could the expression of CD86 and FcγRIIB on B cells be functionally related and involved in driving rheumatoid arthritis?

C. Mauri, E. Jury, 2010, Arthritis research & therapy.

Positive predictive value for malignancy on surgical excision of breast lesions of uncertain malignant potential (B3) diagnosed by stereotactic vacuum-assisted needle core biopsy (VANCB): a large multi-institutional study in Italy.

A. Ancona, S. Bianchi, D. Palli, 2011, Breast.

Standardizing terms, definitions and concepts for describing and interpreting unwanted immunogenicity of biopharmaceuticals: recommendations of the Innovative Medicines Initiative ABIRISK consortium

E. Havrdová, X. Mariette, S. Lacroix-Desmazes, 2015, Clinical and experimental immunology.

Human regulatory B cells in health and disease: therapeutic potential

M. Menon, C. Mauri, 2017, The Journal of clinical investigation.

Immune regulatory function of B cells.

C. Mauri, A. Bosma, 2012, Annual review of immunology.

CD19(+)CD24(hi)CD38(hi) B cells exhibit regulatory capacity in healthy individuals but are functionally impaired in systemic Lupus Erythematosus patients.

D. Isenberg, D. Rawlings, M. Ehrenstein, 2010, Immunity.

Exacerbated experimental arthritis in Wiskott–Aldrich syndrome protein deficiency: Modulatory role of regulatory B cells

L. Notarangelo, S. Burns, A. Thrasher, 2014, European journal of immunology.

Th17 cells are restrained by Treg cells via the inhibition of interleukin-6 in patients with rheumatoid arthritis responding to anti-tumor necrosis factor antibody therapy.

D. Isenberg, D. Nguyen, M. Ehrenstein, 2012, Arthritis and rheumatism.

CD1d-dependent immune suppression mediated by regulatory B cells through modulations of iNKT cells

I. Drozdov, E. Rosser, C. Mauri, 2018, Nature Communications.

Microbiota-Derived Metabolites Suppress Arthritis by Amplifying Aryl-Hydrocarbon Receptor Activation in Regulatory B Cells

André F. Rendeiro, S. Eaton, I. Drozdov, 2020, Cell metabolism.

B Cell Activation and B Cell Tolerance

C. Mauri, V. Reddy, P. Blair, 2020, The Autoimmune Diseases.

The survival and function of IL-10-producing regulatory B cells are negatively controlled by SLAMF5

M. Kramer, C. Mauri, R. Aharoni, 2021, Nature Communications.

A clinical update on the significance of the gut microbiota in systemic autoimmunity.

E. Rosser, C. Mauri, 2016, Journal of autoimmunity.

Regulatory B cells are induced by gut microbiota–driven interleukin-1β and interleukin-6 production

Simon A. Jones, E. Rosser, N. Klein, 2014, Nature Medicine.

Atorvastatin Inhibits Autoreactive B Cell Activation and Delays Lupus Development in New Zealand Black/White F1 Mice1

M. Ehrenstein, H. Cook, C. Mauri, 2004, The Journal of Immunology.

Cellular targets of regulatory B cell-mediated suppression.

E. Rosser, C. Mauri, P. Blair, 2014, Molecular immunology.

Cells of the synovium in rheumatoid arthritis

Claudia Mauri, Michael R. Ehrenstein, M. Ehrenstein, 2007 .

Compromised Function of Regulatory T Cells in Rheumatoid Arthritis and Reversal by Anti-TNFα Therapy

D. Isenberg, G. Warnes, M. Ehrenstein, 2004, The Journal of experimental medicine.

Clinicogenomic factors of biotherapy immunogenicity in autoimmune disease: A prospective multicohort study of the ABIRISK consortium

X. Montalban, P. Dönnes, H. Hartung, 2020, PLoS medicine.

Case report 358

G. Crisi, C. Mauri, M. Calò, 2004, Skeletal Radiology.

Suckling CD1 mice as an animal model for studies of Legionella pneumophila virulence.

E. Proietti, P. Chiani, A. Cassone, 1997, Journal of medical microbiology.

CD19+CD24hiCD38hi B Cells Maintain Regulatory T Cells While Limiting TH1 and TH17 Differentiation

D. Isenberg, M. Ehrenstein, C. Mauri, 2013, Science Translational Medicine.

A Regulatory Feedback between Plasmacytoid Dendritic Cells and Regulatory B Cells Is Aberrant in Systemic Lupus Erythematosus

D. Isenberg, M. Menon, C. Mauri, 2016, Immunity.

Monocyte NOTCH2 expression predicts IFN-β immunogenicity in multiple sclerosis patients.

P. Dönnes, B. Hemmer, Karel Medek, 2018, JCI insight.

B regulatory cells and the tumor-promoting actions of TNF-α during squamous carcinogenesis

L. Coussens, F. Balkwill, E. Rosser, 2011, Proceedings of the National Academy of Sciences.

Restoring the balance: Harnessing regulatory T cells for therapy in rheumatoid arthritis

M. Ehrenstein, C. Mauri, F. Flores-Borja, 2008, European journal of immunology.

Therapeutic activity of agonistic monoclonal antibodies against CD40 in a chronic autoimmune inflammatory process

Claudia Mauri, Marco Londei, M. Londei, 2000, Nature Medicine.

sciCSR infers B cell state transition and predicts class-switch recombination dynamics using single-cell transcriptomic data

F. Fraternali, C. Mauri, D. Dunn-Walters, 2023, bioRxiv.

Relationship between Th1/Th2 cytokine patterns and the arthritogenic response in collagen‐induced arthritis

Claudia Mauri, M. Feldmann, Richard O. Williams, 1996, European journal of immunology.

B Cells in Experimental Arthritis Novel Suppressive Function of Transitional 2

D. Rawlings, M. Ehrenstein, C. Mauri, 2007 .

[Lymphoid myelofibrosis].

C. Mauri, 1975, Minerva medica.

Statins for atherosclerosis--as good as it gets?

M. Ehrenstein, C. Mauri, E. Jury, 2005, The New England journal of medicine.

Magnetic Resonance Imaging and Ultrasonography in Predicting Infiltrating Residual Disease after Preoperative Chemotherapy in Stage II–III Breast Cancer

M. Dieci, P. Conte, F. Piacentini, 2011, Annals of Surgical Oncology.

Inactive disease in patients with lupus is linked to autoantibodies to type I interferons that normalize blood IFNα and B cell subsets

D. Isenberg, P. Peterson, M. Menon, 2023, Cell reports. Medicine.

Atorvastatin Restores Lck Expression and Lipid Raft-Associated Signaling in T Cells from Patients with Systemic Lupus Erythematosus1

D. Isenberg, M. Ehrenstein, C. Mauri, 2006, The Journal of Immunology.

Response to Biologic Drugs in Patients With Rheumatoid Arthritis and Antidrug Antibodies

X. Mariette, N. de Vries, M. Pallardy, 2023, JAMA Network Open.

Signalling defects and cellular interactions (2)

C. Mauri, S. Datta, 2008, Lupus.

Treatment of newly established transgenic model of chronic relapsing arthritis with non-depleting anti CD4 monocional antibody

D. Woodrow, L. Mori, M. Londei, 1997 .

The Biology of phagocytes in health and disease

G. Ricevuti, C. Mauri, S. Rizzo, 1987 .

Activation and Delays Lupus Development in Atorvastatin Inhibits Autoreactive B Cell

M. Ehrenstein, C. Mauri, E. Jury, 2004 .